Data and Information
It has shown 96% accuracy in predicting fall risks in over 70,000 outpatients in Japan.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.
Rad AI's genAI tools will be offered through Bayer's vendor-neutral Calantic Digital Solution marketplace, which provides AI-enabled clinical and operational applications.
The New York-based company will use the funds to grow its team, continue expanding into health systems and accelerate product innovation.
Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.
Interestingly, young physicians see more risk to it than their senior counterparts.
The company offers a clinical vetting process and care-management pathway for individuals suffering from substance use disorders.
The organizations will codevelop algorithms to help healthcare professionals analyze point-of-care ultrasound images for cardiac care.
Cardiac and lung-disease platform Eko Health secured $41 million in Series D funding.
CasePointer's workforce will join Deloitte, and the company will use the business's software in conjunction with its GovConnect assets to assist its government clients.